Phathom Pharmaceuticals, Inc. PHAT Other Noncash Income (Expense)
Other Noncash Income (Expense) at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s other noncash income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s other noncash income (expense)?
- Phathom Pharmaceuticals, Inc. (PHAT) reported other noncash income (expense) of -$1.61M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s other noncash income (expense) changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s other noncash income (expense) increased by 11.3% year-over-year, from -$1.81M to -$1.61M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s other noncash income (expense)?
- Over 4 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s other noncash income (expense) has grown at a 58.6% compound annual growth rate (CAGR), from -$823K to -$5.21M.
- What does other noncash income (expense) mean?
- This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.